GOOD VENOM

February 23, 2017 Scipreneur Private Limited 0

GOOD VENOM February 23, 2017 By: University of Buffalo The problems began sometime before JB turned 2. He was, by appearance, a healthy boy. He had a brilliant smile, striking blonde hair and eyes the color of the sea. He was fast becoming enamored with the stuff of boyhood: cars, [..]

Mount Sinai Scientists Develops A New Reference Database (RepurposeDB) of Drug Repositioning and Decodes Molecular Code of Therapeutic Reuse

February 21, 2017 Scipreneur Private Limited 0

Mount Sinai Scientists Develops A New Reference Database (RepurposeDB) of Drug Repositioning and Decodes Molecular Code of Therapeutic Reuse By: Vijay Soni, Ph.D. | Founder & C.E.O Scipreneur February 21, 2017 A drug discovery project takes 8-12 years and costs 8-15 billion dollars. It relies on various avenues of pre-clinical development, [..]

Turning Food Poisoning Microbe Into Powerful Cancer Fighter

February 18, 2017 Scipreneur Private Limited 0

Turning Food Poisoning Microbe Into Powerful Cancer Fighter February 18, 2017 Source: Science Translational Medicine Cancer tends to stick around because it’s practically invisible to the body’s own defenses: The immune system doesn’t recognize the rogue cells because they aren’t foreign invaders. To activate the immune system to attack cancer, scientists [..]

Phase II study supports potential for Roche’s TECENTRIQ (atezolizumab) plus Avastin (bevacizumab) for local, advanced or metastatic renal cell carcinoma

February 18, 2017 Scipreneur Private Limited 0

Phase II study supports potential for Roche’s TECENTRIQ (atezolizumab) plus Avastin (bevacizumab) for local, advanced or metastatic renal cell carcinoma Study results also showed encouraging efficacy compared to sunitinib in those people whose disease expressed the PD-L1 (programmed death-ligand 1) protein Roche is evaluating TECENTRIQ plus Avastin in a Phase [..]

Novel Direction Towards Diabetes Cure

February 15, 2017 Scipreneur Private Limited 0

Novel Direction Towards Diabetes Cure By: Vijay Soni, Ph.D. | Founder and C.E.O. of Scipreneur A team of researchers at Weill Cornell Medical College (WCMC), New York have identified a novel trafficking pathway for a G-protein-coupled receptor (GPCR, the largest family of signaling receptors). The group has studied the trafficking [..]

10 Must Watch TED Talks for Every Entrepreneur

February 12, 2017 Scipreneur Private Limited 0

10 Must Watch TED Talks for Every Entrepreneur By: Vijay Soni, Ph.D. | Founder & C.E.O Scipreneur TED Talks are my favorite as they are full of vision on everything; from everyday science to advance level of scientific developments and from basic human nature to intricacies of life. They are real life experiences; [..]

FDA Approves Drug to Treat Duchenne Muscular Dystrophy

February 12, 2017 Scipreneur Private Limited 0

FDA Approves Drug to Treat Duchenne Muscular Dystrophy By: Marathon Pharma News February 9, 2017 Marathon Pharmaceuticals, LLC (Marathon), a U.S. research-based biopharmaceutical company focused solely on the development of new treatments for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of EMFLAZA™ (deflazacort) [..]

Startup Events In USA : February 2017

February 4, 2017 Scipreneur Private Limited 0

Startup Events In USA : February 2017 By: Vijay Soni, PhD, Founder & C.E.O. Scipreneur Whether you are starting a business just now, or you are already running a company, or you are just curious about what might be the business, entrepreneurship, technology, or digital marketing trends of tomorrow, this [..]

Microbial manufacturing

February 4, 2017 Scipreneur Private Limited 0

Microbial manufacturing By: Rob Matheson | MIT News Office February 4, 2017 Using advanced fermentation technology, industrial biotech startup Manus Bio hopes to make manufacturing flavors, fragrances, and other products greener and more cost-effective — and maybe create new products in the process. The MIT spinout has created a low-cost [..]